1
Evolving Treatment of Paravisceral & Thoracoabdominal Aortic Disease
Richard P. Cambria, M.D.
Systems Chief Vascular Services, and Chief of Vascular and Endovascular Surgery, Steward Health Care System and St. Elizabeth’s Medical Center, Boston MA. Robert R. Linton MD Professor of Vascular & Endovascular Surgery, Harvard Medical School (Emeritus)
- The Boston origins and evolution of surgery of the
DTA/TAAA (Paravisceral vs Type IV TAA vs Type I- III TAA)
- Evolution of operative strategies and adjuncts
SCI
- The impact and evolution of TEVAR and
EVAR Relevant??
- Role of Open Surgery 2019 and beyond
OUTLINE
1 2